Tags: Drug.

Bosentan is a dual endothelin receptor antagonist used in the treatment of pulmonary artery hypertension (PAH). It is licensed in the United States the European Union and other countries by Actelion Pharmaceuticals for the management of PAH under the trade name Tracleer.

Bosentan.svg
ATC prefix
C02
ATC suffix
KX01
Bioavailability
50.0
CAS number
147536-97-8
ChEBI
51450
DrugBank
DB00559
FDA UNII code
XUL93R30K2
IUPAC name
4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]benzene-1-sulfonamide
PubChem
104865

Loading...

This page contains content from the copyrighted Wikipedia article "Bosentan"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.